1. Home
  2. OSPN vs ABVX Comparison

OSPN vs ABVX Comparison

Compare OSPN & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSPN
  • ABVX
  • Stock Information
  • Founded
  • OSPN 1991
  • ABVX 2013
  • Country
  • OSPN United States
  • ABVX France
  • Employees
  • OSPN N/A
  • ABVX N/A
  • Industry
  • OSPN EDP Services
  • ABVX
  • Sector
  • OSPN Technology
  • ABVX
  • Exchange
  • OSPN Nasdaq
  • ABVX Nasdaq
  • Market Cap
  • OSPN 688.4M
  • ABVX 722.3M
  • IPO Year
  • OSPN 1998
  • ABVX N/A
  • Fundamental
  • Price
  • OSPN $18.25
  • ABVX $7.65
  • Analyst Decision
  • OSPN Strong Buy
  • ABVX Strong Buy
  • Analyst Count
  • OSPN 5
  • ABVX 6
  • Target Price
  • OSPN $16.50
  • ABVX $38.67
  • AVG Volume (30 Days)
  • OSPN 436.0K
  • ABVX 132.7K
  • Earning Date
  • OSPN 10-30-2024
  • ABVX 09-09-2024
  • Dividend Yield
  • OSPN N/A
  • ABVX N/A
  • EPS Growth
  • OSPN N/A
  • ABVX N/A
  • EPS
  • OSPN 0.75
  • ABVX N/A
  • Revenue
  • OSPN $244,936,000.00
  • ABVX $9,676,417.00
  • Revenue This Year
  • OSPN $4.28
  • ABVX $31.67
  • Revenue Next Year
  • OSPN $3.43
  • ABVX $1,189.66
  • P/E Ratio
  • OSPN $24.49
  • ABVX N/A
  • Revenue Growth
  • OSPN 7.05
  • ABVX 100.87
  • 52 Week Low
  • OSPN $9.22
  • ABVX $7.11
  • 52 Week High
  • OSPN $19.58
  • ABVX $17.02
  • Technical
  • Relative Strength Index (RSI)
  • OSPN 51.55
  • ABVX 37.23
  • Support Level
  • OSPN $17.84
  • ABVX $7.49
  • Resistance Level
  • OSPN $19.58
  • ABVX $8.18
  • Average True Range (ATR)
  • OSPN 0.75
  • ABVX 0.46
  • MACD
  • OSPN -0.15
  • ABVX 0.00
  • Stochastic Oscillator
  • OSPN 35.44
  • ABVX 28.27

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.

Share on Social Networks: